DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Morgan Stanley Maintains Equal-Weight on Immunomedics, Raises Price Target to $19

Morgan Stanley maintains Immunomedics (NASDAQ:IMMU) with a Equal-Weight and raises the price target from $17 to $19.

Benzinga · 03/03/2020 13:14

Morgan Stanley maintains Immunomedics (NASDAQ:IMMU) with a Equal-Weight and raises the price target from $17 to $19.